✦ LIBER ✦

Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma

✍ Scribed by Sauer, Maike; Plütschow, Annette; Jachimowicz, Ron D.; Kleefisch, Dominik; Reiners, Katrin S.; Ponader, Sabine; Engert, Andreas; von Strandmann, Elke Pogge

Book ID: 118751089
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 183 KB
Volume: 88
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23361

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discriminant analysis involving serum cy

Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma

✍ Kowalska, Maria; Tajer, Joanna; Chechlinska, Magdalena; Fuksiewicz, Malgorzata; 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 144 KB

Early changes in serum IL-6 and VEGF lev

Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin’s lymphoma

✍ Lars Møller Pedersen; Tobias Wirenfeldt Klausen; Ulla Høy Davidsen; Hans Erik Jo 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 135 KB

Elevated serum endostatin is associated

Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma

✍ Petri Bono; Lasse Teerenhovi; Heikki Joensuu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND Endostatin is a cleaved fragment of collagen Type XVIII and has antiangiogenic activity. The clinical significance of circulating, soluble endostatin (S‐endostatin) is not known. ## METHODS Pretreatment S‐endostatin and serum vascular endothelial growth factor (S‐VEGF)

Elevated Serum Creatinine at Baseline Pr

Elevated Serum Creatinine at Baseline Predicts Poor Outcome in Patients Receiving Cardiac Resynchronization Therapy

✍ ALAA SHALABY; AIMAN El-SAED; ANDREW VOIGT; CONSTANTINE ALBANY; SAMIR SABA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

High serum hepatocyte growth factor leve

High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma

✍ Liang-Tsai Hsiao; Jen-Tsun Lin; I-Ting Yu; Tzeon-Jye Chiou; Jin-Hwang Liu; Chueh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Serum BLyS levels increase after rituxim

Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma

✍ Stephen M. Ansell; Anne J. Novak; Steven Ziesmer; Tammy Price-Troska; Betsy LaPl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views